Sector
PharmaceuticalsOpen
₹2.1Prev. Close
₹2.2Turnover(Lac.)
₹0.01Day's High
₹2.1Day's Low
₹2.152 Week's High
₹052 Week's Low
₹0Book Value
₹-35.74Face Value
₹10Mkt Cap (₹ Cr.)
5.05P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 | Mar-2010 |
|---|---|---|---|
Equity Capital | 24.04 | 24.04 | 24.04 |
Preference Capital | 0 | 0 | 0 |
Reserves | -83.21 | -66 | -1.69 |
Net Worth | -59.17 | -41.96 | 22.35 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Revenue | 26.46 | 28.4 |
yoy growth (%) | -6.83 | |
Raw materials | -4.7 | -7.81 |
As % of sales | 17.76 | 27.51 |
Employee costs | -9.64 | -9.35 |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Profit before tax | -17.21 | -45.12 |
Depreciation | -9.13 | -22.34 |
Tax paid | 0 | -7.69 |
Working capital | -7.93 | |
Other operating items |
| Y/e 31 Mar | Mar-2012 | Mar-2011 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | -6.83 | |
Op profit growth | -87.36 | |
EBIT growth | -72.79 | |
Net profit growth | -73.23 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Nalin Bamzai
Director (Technical)
Rajesh Agrawal
Director
Sanjay Sinha
Director
Yogendra Kumar Chauhan
Company Secretary
Manish Bhojwani
Additional Director
Avantika Varma
Savroli Village,
Khalapur Taluka,
Maharashtra - 410202
Tel: 91-2192-274026-29
Website: http://www.kdlbiotech.com
Email: kopran@giasbm01.vsnl.net.in
E-2/3 Saki Vihar Rd,
Ansa Indl Estate, Saki Naka Andheri-E,
Mumbai - 400 072
Tel: 91-22-40430200
Website: www.bigshareonline.com
Email: info@bigshareonline.com
Summary
Promoted by the Parijat Enterprises, Kopran is currently an integrated health care company. The company has used research-based technology to contribute towards total health-care. From diagnostics to ...
Read More
Reports by KDL Biotech Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.